(VRML:Consolidated Issue listed on NASDAQ Capital Market)
Gordon Whiteley Ph.D.
Former Member of Scientific Advisory Board, Vermillion, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
Dr. Gordon Whiteley, PhD. serves as Director of the Antibody Characterization Lab for SAIC-Frederick, a part of the Clinical Proteomics Technologies for Cancer Initiative of the National Cancer Institute Director. Prior to coming to SAIC, Dr. Whiteley served as Vice President of Research and Development at PB Diagnostics / Dade-Behring where he was part of the original development team responsible for the development and commercialization of tests for a wide variety ...
Building IIIPhone: 512-519-0400
Austin, Texas 78738
Board Members Memberships*There is no Board Members Memberships data available.
University of Toronto
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Russell Cummings||Chief Executive Officer, Executive Director and Member of Investment Committee|
Imperial Innovations Group plc
|Kevin B. Kowbel||Chairman and Interim Chief Executive Officer|
Health Discovery Corporation
|Christopher J. Moreau||Chief Executive Officer, President and Non Independent Director|
|Rene A. Schena||Chairman and Chief Executive Officer|
|Jan Groen Ph.D.||Chief Executive Officer and Executive Director|
|€470.7K||Compensation as of Fiscal Year 2014.|